Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial
- 1 September 2019
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 215, 147-156
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NSF-12-512)
- Samsung
- National Heart, Lung, and Blood Institute
- Medtronic
- American Heart Association (18SFRN34110082)
- National Center for Complementary and Integrative Health
- Boehringer Ingelheim
- Johnson and Johnson
- National Science Foundation (1RO1HL092577, K24HL105780, R01HL128914)
- Merck
- Pfizer
- Biotronik
- Philips
- Bayer
- Broad Institute
- Abbott Laboratories
- Quest Diagnostics
- Bristol-Myers Squibb
- Fondation Leducq (14CVD01, 18SFRN34250007, 1R01HL139731)
This publication has 40 references indexed in Scilit:
- Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF ConsortiumJournal of the American Heart Association, 2013
- Allocation techniques for balance at baseline in cluster randomized trials: a methodological reviewTrials, 2012
- Subclinical Atrial Fibrillation and the Risk of StrokeNew England Journal of Medicine, 2012
- The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke RiskCirculation: Arrhythmia and Electrophysiology, 2009
- Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trialBMJ, 2007
- Atrial Fibrillation and Stroke in the General Medicare PopulationStroke, 2006
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- Bayesian inference for causal effects in randomized experiments with noncomplianceThe Annals of Statistics, 1997
- Newly Diagnosed Atrial Fibrillation and Acute StrokeStroke, 1995
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991